UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:SOGA3-LOXL2 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: SOGA3-LOXL2 | FusionPDB ID: 85145 | FusionGDB2.0 ID: 85145 | Hgene | Tgene | Gene symbol | SOGA3 | LOXL2 | Gene ID | 387104 | 4017 |
Gene name | SOGA family member 3 | lysyl oxidase like 2 | |
Synonyms | C6orf174|dJ403A15.3 | LOR|LOR2|WS9-14 | |
Cytomap | 6q22.33 | 8p21.3 | |
Type of gene | protein-coding | protein-coding | |
Description | protein SOGA3 | lysyl oxidase homolog 2lysyl oxidase related 2lysyl oxidase-like 2 delta e13lysyl oxidase-like 2 proteinlysyl oxidase-like protein 2lysyl oxidase-related protein 2lysyl oxidase-related protein WS9-14 | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | . | Q9Y4K0 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000368268, ENST00000481848, ENST00000525778, ENST00000556132, ENST00000474293, ENST00000465909, | ENST00000518472, ENST00000389131, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 3 X 2 X 3=18 | 8 X 4 X 7=224 |
# samples | 3 | 8 | |
** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(8/224*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: SOGA3 [Title/Abstract] AND LOXL2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | SOGA3(127796438)-LOXL2(23198716), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | SOGA3-LOXL2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. SOGA3-LOXL2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. SOGA3-LOXL2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. SOGA3-LOXL2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. SOGA3-LOXL2 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | LOXL2 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 25959397 |
Tgene | LOXL2 | GO:0001837 | epithelial to mesenchymal transition | 16096638 |
Tgene | LOXL2 | GO:0006464 | cellular protein modification process | 23319596 |
Tgene | LOXL2 | GO:0018057 | peptidyl-lysine oxidation | 25959397|27735137|29581294 |
Tgene | LOXL2 | GO:0045892 | negative regulation of transcription, DNA-templated | 16096638 |
Tgene | LOXL2 | GO:0046688 | response to copper ion | 23319596 |
Fusion gene breakpoints across SOGA3 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across LOXL2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-A4IY-01A | SOGA3 | chr6 | 127796438 | - | LOXL2 | chr8 | 23198716 | - |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000481848 | SOGA3 | chr6 | 127796438 | - | ENST00000389131 | LOXL2 | chr8 | 23198716 | - | 5892 | 3244 | 511 | 5037 | 1508 |
ENST00000556132 | SOGA3 | chr6 | 127796438 | - | ENST00000389131 | LOXL2 | chr8 | 23198716 | - | 6246 | 3598 | 865 | 5391 | 1508 |
ENST00000368268 | SOGA3 | chr6 | 127796438 | - | ENST00000389131 | LOXL2 | chr8 | 23198716 | - | 5381 | 2733 | 0 | 4526 | 1508 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000481848 | ENST00000389131 | SOGA3 | chr6 | 127796438 | - | LOXL2 | chr8 | 23198716 | - | 0.005321634 | 0.9946784 |
ENST00000556132 | ENST00000389131 | SOGA3 | chr6 | 127796438 | - | LOXL2 | chr8 | 23198716 | - | 0.006720236 | 0.99327976 |
ENST00000368268 | ENST00000389131 | SOGA3 | chr6 | 127796438 | - | LOXL2 | chr8 | 23198716 | - | 0.003805105 | 0.99619496 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >85145_85145_1_SOGA3-LOXL2_SOGA3_chr6_127796438_ENST00000368268_LOXL2_chr8_23198716_ENST00000389131_length(amino acids)=1508AA_BP=909 MSQPPIGGAAPATAAASPAAAATEARLHPEGSSRKQQRAQSPARPRDSSLRQTIAATRSPVGAGTKLNSVRQQQLQQQQQQGNKTGSRTG PPASIRGGGGGAEKATPLAPKGAAPGAVQPVAGAEAAPAATLAALGGRRPGPPEEPPRELESVPSKLGEPPPLGEGGGGGGEGGGAGGGS GEREGGAPQPPPPRGWRGKGVRAQQRGGSGGEGASPSPSSSSAGKTPGTGSRNSGSGVAGGGSGGGGSYWKEGCLQSELIQFHLKKERAA AAAAAAQMHAKNGGGSSSRSSPVSGPPAVCETLAVASASPMAAAAEGPQQSAEGSASGGGMQAAAPPSSQPHPQQLQEQEEMQEEMEKLR EENETLKNEIDELRTEMDEMRDTFFEEDACQLQEMRHELERANKNCRILQYRLRKAERKRLRYAQTGEIDGELLRSLEQDLKVAKDVSVR LHHELENVEEKRTTTEDENEKLRQQLIEVEIAKQALQNELEKMKELSLKRRGSKDLPKSEKKAQQTPTEEDNEDLKCQLQFVKEEAALMR KKMAKIDKEKDRFEHELQKYRSFYGDLDSPLPKGEAGGPPSTREAELKLRLRLVEEEANILGRKIVELEVENRGLKAELDDLRGDDFNGS ANPLMREQSESLSELRQHLQLVEDETELLRRNVADLEEQNKRITAELNKYKYKSGGHDSARHHDNAKTEALQEELKAARLQINELSGKVM QLQYENRVLMSNMQRYDLASHLGIRGSPRDSDAESDAGKKESDDDSRPPHRKREGPIGGESDSEEVRNIRCLTPTRSFYPAPGPWPKSFS DRQQMKDIRSEAERLGKTIDRLIADTSTIITEARIYVANGDLFGLMDEEDDGSRIREHELLYRINAQMKAFRKELQTFIDRLEVPKSADD RGAEEPISVSQNLNIQVEDIRIRAILSTYRKRTPVMEGYVEVKEGKTWKQICDKHWTAKNSRVVCGMFGFPGERTYNTKVYKMFASRRKQ RYWPFSMDCTGTEAHISSCKLGPQVSLDPMKNVTCENGLPAVVSCVPGQVFSPDGPSRFRKAYKPEQPLVRLRGGAYIGEGRVEVLKNGE WGTVCDDKWDLVSASVVCRELGFGSAKEAVTGSRLGQGIGPIHLNEIQCTGNEKSIIDCKFNAESQGCNHEEDAGVRCNTPAMGLQKKLR LNGGRNPYEGRVEVLVERNGSLVWGMVCGQNWGIVEAMVVCRQLGLGFASNAFQETWYWHGDVNSNKVVMSGVKCSGTELSLAHCRHDGE DVACPQGGVQYGAGVACSETAPDLVLNAEMVQQTTYLEDRPMFMLQCAMEENCLSASAAQTDPTTGYRRLLRFSSQIHNNGQSDFRPKNG RHAWIWHDCHRHYHSMEVFTHYDLLNLNGTKVAEGHKASFCLEDTECEGDIQKNYECANFGDQGITMGCWDMYRHDIDCQWVDITDVPPG -------------------------------------------------------------- >85145_85145_2_SOGA3-LOXL2_SOGA3_chr6_127796438_ENST00000481848_LOXL2_chr8_23198716_ENST00000389131_length(amino acids)=1508AA_BP=909 MSQPPIGGAAPATAAASPAAAATEARLHPEGSSRKQQRAQSPARPRDSSLRQTIAATRSPVGAGTKLNSVRQQQLQQQQQQGNKTGSRTG PPASIRGGGGGAEKATPLAPKGAAPGAVQPVAGAEAAPAATLAALGGRRPGPPEEPPRELESVPSKLGEPPPLGEGGGGGGEGGGAGGGS GEREGGAPQPPPPRGWRGKGVRAQQRGGSGGEGASPSPSSSSAGKTPGTGSRNSGSGVAGGGSGGGGSYWKEGCLQSELIQFHLKKERAA AAAAAAQMHAKNGGGSSSRSSPVSGPPAVCETLAVASASPMAAAAEGPQQSAEGSASGGGMQAAAPPSSQPHPQQLQEQEEMQEEMEKLR EENETLKNEIDELRTEMDEMRDTFFEEDACQLQEMRHELERANKNCRILQYRLRKAERKRLRYAQTGEIDGELLRSLEQDLKVAKDVSVR LHHELENVEEKRTTTEDENEKLRQQLIEVEIAKQALQNELEKMKELSLKRRGSKDLPKSEKKAQQTPTEEDNEDLKCQLQFVKEEAALMR KKMAKIDKEKDRFEHELQKYRSFYGDLDSPLPKGEAGGPPSTREAELKLRLRLVEEEANILGRKIVELEVENRGLKAELDDLRGDDFNGS ANPLMREQSESLSELRQHLQLVEDETELLRRNVADLEEQNKRITAELNKYKYKSGGHDSARHHDNAKTEALQEELKAARLQINELSGKVM QLQYENRVLMSNMQRYDLASHLGIRGSPRDSDAESDAGKKESDDDSRPPHRKREGPIGGESDSEEVRNIRCLTPTRSFYPAPGPWPKSFS DRQQMKDIRSEAERLGKTIDRLIADTSTIITEARIYVANGDLFGLMDEEDDGSRIREHELLYRINAQMKAFRKELQTFIDRLEVPKSADD RGAEEPISVSQNLNIQVEDIRIRAILSTYRKRTPVMEGYVEVKEGKTWKQICDKHWTAKNSRVVCGMFGFPGERTYNTKVYKMFASRRKQ RYWPFSMDCTGTEAHISSCKLGPQVSLDPMKNVTCENGLPAVVSCVPGQVFSPDGPSRFRKAYKPEQPLVRLRGGAYIGEGRVEVLKNGE WGTVCDDKWDLVSASVVCRELGFGSAKEAVTGSRLGQGIGPIHLNEIQCTGNEKSIIDCKFNAESQGCNHEEDAGVRCNTPAMGLQKKLR LNGGRNPYEGRVEVLVERNGSLVWGMVCGQNWGIVEAMVVCRQLGLGFASNAFQETWYWHGDVNSNKVVMSGVKCSGTELSLAHCRHDGE DVACPQGGVQYGAGVACSETAPDLVLNAEMVQQTTYLEDRPMFMLQCAMEENCLSASAAQTDPTTGYRRLLRFSSQIHNNGQSDFRPKNG RHAWIWHDCHRHYHSMEVFTHYDLLNLNGTKVAEGHKASFCLEDTECEGDIQKNYECANFGDQGITMGCWDMYRHDIDCQWVDITDVPPG -------------------------------------------------------------- >85145_85145_3_SOGA3-LOXL2_SOGA3_chr6_127796438_ENST00000556132_LOXL2_chr8_23198716_ENST00000389131_length(amino acids)=1508AA_BP=909 MSQPPIGGAAPATAAASPAAAATEARLHPEGSSRKQQRAQSPARPRDSSLRQTIAATRSPVGAGTKLNSVRQQQLQQQQQQGNKTGSRTG PPASIRGGGGGAEKATPLAPKGAAPGAVQPVAGAEAAPAATLAALGGRRPGPPEEPPRELESVPSKLGEPPPLGEGGGGGGEGGGAGGGS GEREGGAPQPPPPRGWRGKGVRAQQRGGSGGEGASPSPSSSSAGKTPGTGSRNSGSGVAGGGSGGGGSYWKEGCLQSELIQFHLKKERAA AAAAAAQMHAKNGGGSSSRSSPVSGPPAVCETLAVASASPMAAAAEGPQQSAEGSASGGGMQAAAPPSSQPHPQQLQEQEEMQEEMEKLR EENETLKNEIDELRTEMDEMRDTFFEEDACQLQEMRHELERANKNCRILQYRLRKAERKRLRYAQTGEIDGELLRSLEQDLKVAKDVSVR LHHELENVEEKRTTTEDENEKLRQQLIEVEIAKQALQNELEKMKELSLKRRGSKDLPKSEKKAQQTPTEEDNEDLKCQLQFVKEEAALMR KKMAKIDKEKDRFEHELQKYRSFYGDLDSPLPKGEAGGPPSTREAELKLRLRLVEEEANILGRKIVELEVENRGLKAELDDLRGDDFNGS ANPLMREQSESLSELRQHLQLVEDETELLRRNVADLEEQNKRITAELNKYKYKSGGHDSARHHDNAKTEALQEELKAARLQINELSGKVM QLQYENRVLMSNMQRYDLASHLGIRGSPRDSDAESDAGKKESDDDSRPPHRKREGPIGGESDSEEVRNIRCLTPTRSFYPAPGPWPKSFS DRQQMKDIRSEAERLGKTIDRLIADTSTIITEARIYVANGDLFGLMDEEDDGSRIREHELLYRINAQMKAFRKELQTFIDRLEVPKSADD RGAEEPISVSQNLNIQVEDIRIRAILSTYRKRTPVMEGYVEVKEGKTWKQICDKHWTAKNSRVVCGMFGFPGERTYNTKVYKMFASRRKQ RYWPFSMDCTGTEAHISSCKLGPQVSLDPMKNVTCENGLPAVVSCVPGQVFSPDGPSRFRKAYKPEQPLVRLRGGAYIGEGRVEVLKNGE WGTVCDDKWDLVSASVVCRELGFGSAKEAVTGSRLGQGIGPIHLNEIQCTGNEKSIIDCKFNAESQGCNHEEDAGVRCNTPAMGLQKKLR LNGGRNPYEGRVEVLVERNGSLVWGMVCGQNWGIVEAMVVCRQLGLGFASNAFQETWYWHGDVNSNKVVMSGVKCSGTELSLAHCRHDGE DVACPQGGVQYGAGVACSETAPDLVLNAEMVQQTTYLEDRPMFMLQCAMEENCLSASAAQTDPTTGYRRLLRFSSQIHNNGQSDFRPKNG RHAWIWHDCHRHYHSMEVFTHYDLLNLNGTKVAEGHKASFCLEDTECEGDIQKNYECANFGDQGITMGCWDMYRHDIDCQWVDITDVPPG -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr6:127796438/chr8:23198716) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | LOXL2 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Mediates the post-translational oxidative deamination of lysine residues on target proteins leading to the formation of deaminated lysine (allysine) (PubMed:27735137). Acts as a transcription corepressor and specifically mediates deamination of trimethylated 'Lys-4' of histone H3 (H3K4me3), a specific tag for epigenetic transcriptional activation (PubMed:27735137). Shows no activity against histone H3 when it is trimethylated on 'Lys-9' (H3K9me3) or 'Lys-27' (H3K27me3) or when 'Lys-4' is monomethylated (H3K4me1) or dimethylated (H3K4me2) (PubMed:27735137). Also mediates deamination of methylated TAF10, a member of the transcription factor IID (TFIID) complex, which induces release of TAF10 from promoters, leading to inhibition of TFIID-dependent transcription (PubMed:25959397). LOXL2-mediated deamination of TAF10 results in transcriptional repression of genes required for embryonic stem cell pluripotency including POU5F1/OCT4, NANOG, KLF4 and SOX2 (By similarity). Involved in epithelial to mesenchymal transition (EMT) via interaction with SNAI1 and participates in repression of E-cadherin CDH1, probably by mediating deamination of histone H3 (PubMed:16096638, PubMed:27735137, PubMed:24414204). During EMT, involved with SNAI1 in negatively regulating pericentromeric heterochromatin transcription (PubMed:24239292). SNAI1 recruits LOXL2 to pericentromeric regions to oxidize histone H3 and repress transcription which leads to release of heterochromatin component CBX5/HP1A, enabling chromatin reorganization and acquisition of mesenchymal traits (PubMed:24239292). Interacts with the endoplasmic reticulum protein HSPA5 which activates the IRE1-XBP1 pathway of the unfolded protein response, leading to expression of several transcription factors involved in EMT and subsequent EMT induction (PubMed:28332555). Involved in E-cadherin repression following hypoxia, a hallmark of EMT believed to amplify tumor aggressiveness, suggesting that it may play a role in tumor progression (PubMed:20026874). When secreted into the extracellular matrix, promotes cross-linking of extracellular matrix proteins by mediating oxidative deamination of peptidyl lysine residues in precursors to fibrous collagen and elastin (PubMed:20306300). Acts as a regulator of sprouting angiogenesis, probably via collagen IV scaffolding (PubMed:21835952). Acts as a regulator of chondrocyte differentiation, probably by regulating expression of factors that control chondrocyte differentiation (By similarity). {ECO:0000250|UniProtKB:P58022, ECO:0000269|PubMed:16096638, ECO:0000269|PubMed:20026874, ECO:0000269|PubMed:20306300, ECO:0000269|PubMed:21835952, ECO:0000269|PubMed:24239292, ECO:0000269|PubMed:24414204, ECO:0000269|PubMed:25959397, ECO:0000269|PubMed:27735137}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000368268 | - | 5 | 8 | 342_726 | 911.0 | 698.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000368268 | - | 5 | 8 | 811_835 | 911.0 | 698.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000525778 | - | 6 | 7 | 342_726 | 911.0 | 948.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000525778 | - | 6 | 7 | 811_835 | 911.0 | 948.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000556132 | - | 6 | 12 | 342_726 | 911.0 | 2488.6666666666665 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000556132 | - | 6 | 12 | 811_835 | 911.0 | 2488.6666666666665 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000368268 | - | 5 | 8 | 269_276 | 911.0 | 698.0 | Compositional bias | Note=Poly-Ala |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000368268 | - | 5 | 8 | 72_81 | 911.0 | 698.0 | Compositional bias | Note=Poly-Gln |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000368268 | - | 5 | 8 | 82_247 | 911.0 | 698.0 | Compositional bias | Note=Gly-rich |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000525778 | - | 6 | 7 | 269_276 | 911.0 | 948.0 | Compositional bias | Note=Poly-Ala |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000525778 | - | 6 | 7 | 72_81 | 911.0 | 948.0 | Compositional bias | Note=Poly-Gln |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000525778 | - | 6 | 7 | 82_247 | 911.0 | 948.0 | Compositional bias | Note=Gly-rich |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000556132 | - | 6 | 12 | 269_276 | 911.0 | 2488.6666666666665 | Compositional bias | Note=Poly-Ala |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000556132 | - | 6 | 12 | 72_81 | 911.0 | 2488.6666666666665 | Compositional bias | Note=Poly-Gln |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000556132 | - | 6 | 12 | 82_247 | 911.0 | 2488.6666666666665 | Compositional bias | Note=Gly-rich |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000368268 | - | 5 | 8 | 915_935 | 911.0 | 698.0 | Transmembrane | Helical |
Tgene | LOXL2 | chr6:127796438 | chr8:23198716 | ENST00000389131 | 2 | 14 | 188_302 | 177.0 | 775.0 | Domain | SRCR 2 | |
Tgene | LOXL2 | chr6:127796438 | chr8:23198716 | ENST00000389131 | 2 | 14 | 326_425 | 177.0 | 775.0 | Domain | SRCR 3 | |
Tgene | LOXL2 | chr6:127796438 | chr8:23198716 | ENST00000389131 | 2 | 14 | 435_544 | 177.0 | 775.0 | Domain | SRCR 4 | |
Tgene | LOXL2 | chr6:127796438 | chr8:23198716 | ENST00000389131 | 2 | 14 | 548_751 | 177.0 | 775.0 | Region | Note=Lysyl-oxidase like |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000525778 | - | 6 | 7 | 915_935 | 911.0 | 948.0 | Transmembrane | Helical |
Hgene | SOGA3 | chr6:127796438 | chr8:23198716 | ENST00000556132 | - | 6 | 12 | 915_935 | 911.0 | 2488.6666666666665 | Transmembrane | Helical |
Tgene | LOXL2 | chr6:127796438 | chr8:23198716 | ENST00000389131 | 2 | 14 | 58_159 | 177.0 | 775.0 | Domain | SRCR 1 |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
SOGA3 | |
LOXL2 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to SOGA3-LOXL2 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to SOGA3-LOXL2 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |